Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA,
Department of Medicine, Geneva University Hospitals, Geneva, Switzerland,
Kidney Blood Press Res. 2019;44(5):1247-1258. doi: 10.1159/000502874. Epub 2019 Sep 2.
BACKGROUND/AIMS: Chronic kidney disease (CKD) is common among patients with heart failure with preserved ejection fraction (HFpEF) and is associated with worse clinical outcomes. This study aims to identify whether the association of CKD with HFpEF is independent of underlying echocardiographic abnormalities.
We conducted a retrospective cohort study including patients without prevalent heart failure referred for echocardiography. Patients with serial echocardiograms, baseline left ventricular ejection fraction (LVEF) ≥50% and estimated glomerular filtration rate (eGFR) ≥90 mL/min/1.73 m2 were matched 1:1 with patients with eGFR <60 mL/min/1.73 m2 for age (±5 years), sex, history of hypertension or diabetes, use of renin-angiotensin inhibitors, and LVEF (±5%). A secondary analysis included patients with preserved LVEF and normal left ventricular mass index matched for the same parameters except use of renin-angiotensin inhibitors.
Patients with CKD were at increased risk for HFpEF admission: crude hazard ratio (HR) 1.79 (95% confidence interval [CI] 1.38-2.32, p < 0.001) and adjusted HR (for coronary disease, loop diuretics, left atrial diameter) 1.64 (95% CI 1.22-2.21, p = 0.001). LVEF and left ventricular diameter decreased over time in both groups but no difference was observed in rate of dropping. Results were similar in the secondary analysis (crude HR 1.99, 95% CI 1.07-3.71, p = 0.03 and HR adjusted for left atrial diameter 1.98, 95% CI 1.05-3.75, p = 0.04). Rate of change was similar for LVEF, pulmonary artery pressure, and left ventricular mass index in both groups.
CKD is independently associated with incident HFpEF despite a similar change in relevant echocardiographic parameters in patients with or without CKD.
背景/目的:慢性肾脏病(CKD)在射血分数保留的心力衰竭(HFpEF)患者中很常见,并且与更差的临床结局相关。本研究旨在确定 CKD 与 HFpEF 的关联是否独立于潜在的超声心动图异常。
我们进行了一项回顾性队列研究,纳入了未患心力衰竭且接受超声心动图检查的患者。对有连续超声心动图、基线左心室射血分数(LVEF)≥50%和估算肾小球滤过率(eGFR)≥90mL/min/1.73m2的患者,按照年龄(±5 岁)、性别、高血压或糖尿病病史、肾素-血管紧张素抑制剂的使用以及 LVEF(±5%)进行 1:1 匹配,与 eGFR<60mL/min/1.73m2 的患者进行匹配。一项二次分析纳入了保留 LVEF 和正常左心室质量指数的患者,这些患者按照除肾素-血管紧张素抑制剂使用之外的相同参数进行匹配。
CKD 患者患 HFpEF 的风险增加:未校正的危险比(HR)为 1.79(95%置信区间 [CI]为 1.38-2.32,p<0.001)和校正的 HR(用于校正冠心病、袢利尿剂、左心房直径)为 1.64(95%CI 为 1.22-2.21,p=0.001)。两组的 LVEF 和左心室直径随时间推移而降低,但下降速度无差异。二次分析结果相似(未校正的 HR 为 1.99,95%CI 为 1.07-3.71,p=0.03;校正左心房直径的 HR 为 1.98,95%CI 为 1.05-3.75,p=0.04)。两组 LVEF、肺动脉压和左心室质量指数的变化率相似。
尽管 CKD 患者和无 CKD 患者的相关超声心动图参数变化相似,但 CKD 与 HFpEF 的发生仍独立相关。